Drug Type Small molecule drug |
Synonyms BMS 954561 |
Target |
Action modulators |
Mechanism Nicotinic receptors modulators |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPhase 2 |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Diabetic peripheral neuropathic pain | Phase 2 | United States | 01 Mar 2011 | |
| Diabetic peripheral neuropathic pain | Phase 2 | France | 01 Mar 2011 | |
| Neuralgia, Postherpetic | Phase 2 | United States | 01 Mar 2011 | |
| Neuralgia, Postherpetic | Phase 2 | France | 01 Mar 2011 |





